Drug Topics June 2023

Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.

Social media marketing is a powerful tool that pharmacists can use.

Employers must make changes in order to hire and retain high-quality talent.

The FDA is working quickly to address shortages of the form used in nebulizers.

Patients may not experience any early symptoms, making screening especially important.

Issues within chain pharmacies have made the profession less attractive for new graduates.

The COVID-19 public health emergency is over. What happens now?

Juliana Reed, executive director of the Biosimilars Forum, discussed the impact of market dynamics and changing pricing structures during a presentation at the 2023 Asembia Specialty Pharmacy Summit.

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.